The International Cerebral Venous Thrombosis Consortium report on cerebral venous thrombosis following vaccination against SARS-CoV-2
- PMID: 34462996
- PMCID: PMC8652852
- DOI: 10.1111/ene.15085
The International Cerebral Venous Thrombosis Consortium report on cerebral venous thrombosis following vaccination against SARS-CoV-2
Conflict of interest statement
Keith W. Muir reports no conflicts of interest.
Richard J Perry was the lead author for the CAIAC Study (Cerebral venous thrombosis After Immunisation Against COVID‐19) cited here as reference 4. He receives funding from The Stroke Association for the SETICOS study (Study Examining The Impact of COVID‐19 On Stroke) and from Randox Laboratories for VOBIS (Validation Of Bioarray In Stroke), both unrelated to vaccination against COVID‐19.
Comment on
-
Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency.Eur J Neurol. 2021 Nov;28(11):3656-3662. doi: 10.1111/ene.15029. Epub 2021 Aug 4. Eur J Neurol. 2021. PMID: 34293217 Free PMC article.
References
-
- Ferro JM, Canhão P, Stam J, et al. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35:664‐670. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources